Literature DB >> 6663988

Blunted kaliuresis after an acute potassium load in patients with chronic renal failure.

G O Perez, R Pelleya, J R Oster, D C Kem, C A Vaamonde.   

Abstract

We evaluated renal handling and plasma potassium (K) and aldosterone (PA) responses to acute oral K loading in 11 patients with tubulointerstitial renal disease (creatinine clearance 32 +/- 5 ml/min [SE] ) and 13 control subjects (creatinine clearance 123 +/- 5). After 4 days of a 10 mEq Na, 50 mEq K diet, the subjects received 0.5 mEq KCl/kg body weight. Prior to KCl there were no differences between the groups in plasma K or urinary K excretion (UKV). In the 4 hr following KCl, less of the load (13 +/- 4%) was excreted by patients than control subjects (54 +/- 5%; P less than 0.001). Plasma K at 3 hr post KCl, and the amount of retained potassium translocated into the intracellular compartment (patients 14 +/- 3; control subjects 7 +/- 2 mEq; P less than 0.05) were significantly higher in the patients than in control subjects. After KCl, PA levels increased in both groups, and the increments in the patients tended to exceed those of controls; patients with hypoaldosteronism, however, transferred less K into cells and had an even greater impairment of renal K excretion than those with normal baseline PA. The results indicate that the impaired response to an acute oral potassium load in chronic renal failure is related primarily to defective renal rather than extrarenal mechanisms.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6663988     DOI: 10.1038/ki.1983.208

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study.

Authors:  Sonal Korgaonkar; Anca Tilea; Brenda W Gillespie; Margaret Kiser; George Eisele; Fredric Finkelstein; Peter Kotanko; Bertram Pitt; Rajiv Saran
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 8.237

Review 2.  Can Novel Potassium Binders Liberate People with Chronic Kidney Disease from the Low-Potassium Diet? A Cautionary Tale.

Authors:  David E St-Jules; Deborah J Clegg; Biff F Palmer; Juan-Jesus Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2021-10-20       Impact factor: 8.237

Review 3.  Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy.

Authors:  Sara S Roscioni; Dick de Zeeuw; Stephan J L Bakker; Hiddo J Lambers Heerspink
Journal:  Nat Rev Nephrol       Date:  2012-10-16       Impact factor: 28.314

Review 4.  Potassium and anaesthesia.

Authors:  J E Tetzlaff; J F O'Hara; M T Walsh
Journal:  Can J Anaesth       Date:  1993-03       Impact factor: 5.063

5.  Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.

Authors:  Georges N Nakhoul; Haiquan Huang; Susana Arrigain; Stacey E Jolly; Jesse D Schold; Joseph V Nally; Sankar D Navaneethan
Journal:  Am J Nephrol       Date:  2015-07-25       Impact factor: 3.754

6.  OACE inhibition does not interfere with acute extrarenal or renal potassium disposal in chronic renal failure.

Authors:  U Zwettler; D Fliser; M Nowicki; E Ritz
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

7.  Haemodynamic consequences of changing potassium concentrations in haemodialysis fluids.

Authors:  Luca Gabutti; Igor Salvadé; Barbara Lucchini; Davide Soldini; Michel Burnier
Journal:  BMC Nephrol       Date:  2011-04-06       Impact factor: 2.388

8.  Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics.

Authors:  Matthew R Weir; Martha R Mayo; Dahlia Garza; Susan A Arthur; Lance Berman; David Bushinsky; Daniel J Wilson; Murray Epstein
Journal:  J Hypertens       Date:  2017-05       Impact factor: 4.844

9.  Changes in urinary potassium excretion in patients with chronic kidney disease.

Authors:  Yuichiro Ueda; Susumu Ookawara; Kiyonori Ito; Haruhisa Miyazawa; Yoshio Kaku; Taro Hoshino; Kaoru Tabei; Yoshiyuki Morishita
Journal:  Kidney Res Clin Pract       Date:  2016-02-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.